Comparative evaluation of efficacy and tolerance of iron polymaltose complex and ferrous sulphate for treatment of iron deficiency anemia in infants
DOI:
https://doi.org/10.31053/1853.0605.v69.n2.21340Keywords:
iron, iron polymaltose complex, ferrous sulphate, anemia, iron deficiencyAbstract
Introduction: Iron deficiency anemia is the most common nutritional deficiency in children under 2 years, affecting to 34.1% in Argentina. Iron supplementation is the standard treatment. The aim of our study was to evaluate the efficacy and tolerability of two iron containing drugs.
Methods: Randomized, double-blind, controlled trial, including children aged 6 to 18 months with iron deficiency anemia (hemoglobin < 11 g/dl, transferrine saturation < 20%). Patients were randomly assigned to one of two treatments: iron polymaltose complex (IPC) or ferrous sulphate (FS). Efficacy, tolerance and adverse events occurrence were evaluated.
Results: 60 children with iron deficiency anemia were included; 29 in the FS group and 31 in the IPC group. There were no significant differences between groups regarding hemoglobin at baseline (10,09 ± 0,92 vs. 10,26 ± 0,41; p= 0,17) and after 90 days treatment (11,26 ± 0,49 vs. 11,14 ± 0,60; p= 0,21).
Also, there were no differences regarding adverse events frequency (FS: 4/29 y IPC: 9/31; p=0,2).
Conclusions: In our study, there were no differences in efficacy and safety between FS and IPC in the treatment of children with iron deficiency anemia.
Downloads
References
Durán P, Mangialavori G, Biglieri A, Kogan L, Abeya Gilardon E. Estudio descriptivo de la situación nutricional en niños de 6-72 meses de la República Argentina. Resultados de la Encuesta Nacional de Nutrición y Salud (ENNyS). Arch Argent Pediatr 2009; 107(5):397-404.
Encuesta Nacional de Nutrición y Salud. Documento de resultados. Ministerio de Salud, Presidencia de la Nación. Buenos Aires; 2006.
Sammartino G. Representaciones culturales acerca de la anemia y la suplementación con hierro. Arch Argent Pediatr 2010; 108(5):401-408.
Walter T, Zacarías I, Yañez CG. Revista del AWGLA (Anemia Working Group Latin America) 2005; 1(1):33-42.
González Aguilar P. Anemia y déficit de hierro en niños y adolescentes. Revista Anemia 2009; 2(2). Disponible en http://www.revistaanemia.org/presentacion-pdf-revista-anemia.php?fileid=r0202&filepdf=gr0pdf2. Accedido el 11 de
junio de 2012.
Johnson G, Jacobs P. Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol 1990; 18:1064-1069.
Comité Nacional de Hematología, Sociedad Argentina de Pediatría. Anemia ferropénica. Guía para el diagnostico y tratamiento.
Arch Argent Pediatr. 2009; 107(4):353-61.
Brock C, Curry H , Hanna C, Knipfer M, Taylor L.. Adverse effects of iron suplementation a comparative trial of WAX matrix iron preparation and convencional ferrous sulfate. Clini Ther 1985; 7(5):568-573.
Toblli JE, Brignoli R. Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis. Arzneimittelforschung. 2007; 57(6A):431-8.
Donato H, Rapetti MC, Morán L, Cavo M. Comparación entre hierro polimaltosa y sulfato ferroso para el tratamiento de la anemia ferropénica: estudio prospectivo aleatorizado. Arch Argent Pediatr 2007; 105(6):491-497.
Suwezda A. Hidróxido férrico polimaltosado contra sulfato ferroso en el tratamiento de la anemia ferropénica [carta]. Arch Argent Pediatr 2008; 106(3):286-287.
Durán P. Anemia por deficiencia de hierro: estrategias disponibles y controversias por resolver. Arch Argent Pediatr 2007; 105(6):488-490.
Almache O et al. Tolerancia y respuesta de hierro polimaltosato versus sulfato, Revista AWGLA 2006; 1(2):44.46.
Stoltzfus RJ. Iron interventions for women and children in low-income countries. J Nutr. 2011; 141(4):756S-762S.
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).